Sequencing from sputum think tank
WGS of Mtb is increasingly used in tuberculosis research. To translate sequencing data into actionable information for the diagnosis and management of tuberculosis patient and for public health surveillance, culture-free WGS directly from clinical samples is needed. Only then could WGS fully unleash its potential and become a transformative game changer for tuberculosis research, clinical care and public health. Through the establishment of a think tank, we aim to move forward in big leaps and accelerate the development of an end-to-end solution for direct WGS of Mtb that is affordable and feasible, even in high tuberculosis burden countries.
List of think tank members (in alphabetical order):
David Alland, Rutgers University, US
Richard Anthony, National Institute for Public Health and the Environment, the Netherlands
Andrea Cabibbe, IRCCS Ospedale San Raffaele, Milan, Italy
Pieter-Jan Ceyssens, ScienSano, Belgium
Daniela Cirillo, IRCCS Ospedale San Raffaele, Milan, Italy
Inaki Comas, Biomedical institute of Valencia, Spain
Derrick Crook, University of Oxford, UK
Vincent Escuyer, Wadsworth Center New York, US
David Engelthaler, Translational Genomics Research Institute, US
Maha Farhat, Harvard Medical School
Sebastian Gagneux, Swiss Tropical and Public Health Institute, Switzerland
Galo Goig, Swiss Tropical and Public Health Institute, Switzerland
Conor Meehan, University of Bradford, UK
Stefan Nieman, Research Center Borstel, Germany
Camus Nimmo, University College London, UK
Shaheed Omar, National Institute for Communicable Diseases, South Africa
Philip Supply, French National Center of Scientific Research, France
Faramaz Valafar, San Diego State University, USA
Koen Vandelannoote, University of Melbourne, Australia
Digby Warner, University of Cape Town, South Africa